• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

TAT International Congress 2019: The home of phase I oncology

Bioengineer by Bioengineer
February 7, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

TAT International Congress 2019 — Paris, France — Feb. 25-27, 2019

Lugano, Switzerland, 7 February 2019 – The European Society for Medical Oncology (ESMO), (1) the leading professional organisation for medical oncology, is pleased to announce the TAT (Targeted Anticancer Therapies) International Congress 2019, (2) the premier forum for discussion of early phase drug developent and translational research.

The Congress, to be held 25-27 February in Paris, France, will bring together around 400 attendees from all over the world and is addressed to basic scientists, physicians and translational researchers from academic settings, industry and regulatory agencies for the common aim of speeding up the development of new anti-cancer treatment for the benefit of cancer patients.

The TAT Congress programme, (3) designed by a faculty of international renown experts, (4) will provide a glimpse into the future of cancer care; major updates and innovation in the field of cancer treatment using exciting novel targeted agents and immunotherapy will be presented along with new points to consider, including the role of liquid biopsies as alternative to conventional tissue biopsies. The issue of combination in the use of immunotherapeutic medicines will be largely discussed as well as new immuno-oncology methodological approaches, the inclusion of children and adolescents in early phase trials and the dynamic change in the distribution of cancer types in those trials.

In addition to the usual congress sessions, dedicated workshops and “Meet the Expert” sessions are planned to allow interactivity among participants.

During the opening session, (5) Dr. Geoffrey Shapiro will be presented the TAT 2019 Honorary Award (6) for his leadership in developmental therapeutics, particularly in solid tumours. Dr. Shapiro will deliver a keynote lecture entitled “Development of Cyclin-Dependent Kinase Inhibitors: A brief history and future directions”.

Media registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration to the TAT International Congress 2019 is free to bona fide journalists on presentation of a letter of assignment and a valid press card.

Media representatives are required to observe and abide by the ESMO Media Policy. (7)

To register as press, please fill out the media registration form. (8)

We look forward to welcoming you in Paris.

###

Further information

ESMO Press Office

[email protected]

Notes to Editors

Please make sure to use the official name of the meeting in your reports: TAT International Congress 2019

Official Congress Hashtag: #TAT19

References

1 European Society for Medical Oncology (ESMO): https://www.esmo.org/

2 TAT 2019 homepage: https://www.esmo.org/Conferences/TAT-2019-International-Congress-on-Targeted-Anticancer-Therapies

3 TAT 2019 programme: https://www.esmo.org/Conferences/TAT-2019-International-Congress-on-Targeted-Anticancer-Therapies/Programme

4 TAT 2019 Congress Officers: https://www.esmo.org/Conferences/TAT-2019-International-Congress-on-Targeted-Anticancer-Therapies/Congress-Officers

5 TAT 2019 Opening Session https://cslide.ctimeetingtech.com/tat2019/attendee/confcal/show/session/1

6 TAT 2019 Honorary Award: https://www.esmo.org/Press-Office/Press-Releases/Cancer-drug-development-award-Shapiro-TAT

7 ESMO Media Policy: https://www.esmo.org/Press-Office/ESMO-Media-Policy

8 Media Registration Form: http://esmo.formstack.com/forms/media_registration_form_tat_2019

About the International Congress on Targeted Anticancer Therapies (TAT)

The TAT Congress is a peculiar ESMO event focusing on early phase drug development and translational research.

The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With more than 20,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide. Visit http://www.esmo.org

Media Contact
ESMO Press Office
[email protected]

Tags: cancerClinical TrialsHealth Care Systems/ServicesHealth ProfessionalsMedical EducationPharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Human Insula-Hippocampus Interaction Drives Memory Encoding

August 4, 2025
blank

Introducing The Lancet Countdown on Health and Plastics: A Groundbreaking Report

August 4, 2025

Experts Launch Initiative to Track Plastic Pollution’s Hidden Threats to Human Health, Warns The Lancet

August 4, 2025

Microglia Chromatin States Reveal Alzheimer’s Spatial Patterns

August 4, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    53 shares
    Share 21 Tweet 13
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Predicting Colorectal Cancer Using Lifestyle Factors

    41 shares
    Share 16 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Widespread Pollution Found in Great Bowerbird Bowers

Breath Test Developed to Detect Colorectal Cancer

Human Insula-Hippocampus Interaction Drives Memory Encoding

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.